- Specialty Peritoneal mesothelioma
-
Stony Brook Cancer Center
Address:1 Lauterbur Drive
Stony Brook, NY 11794
Telephone: (631) 444-8086 - Procedure Cytoreduction with HIPEC
Dr. Sherif Abdel-Misih
Surgical Oncologist
Sherif R. Z. Abdel-Misih, MD, is a surgical oncologist specializing in peritoneal mesothelioma and other abdominal cancers. An expert in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), he provides personalized treatment based on each patient’s needs. Learn more and connect with Dr. Abdel-Misih today.
or call (866) 608-8933
Overview
About Dr. Sherif Abdel-Misih
Dr. Sherif Abdel-Misih is a surgical oncologist with expertise in peritoneal mesothelioma and other cancers that affect the abdomen. He specializes in advanced techniques including cytoreductive surgery with HIPEC, a procedure that can help improve length and quality of life for patients with peritoneal mesothelioma.
Dr. Abdel-Misih also believes cancer care should be personalized, involving a team of mesothelioma specialists working together to provide comprehensive care. This collaborative approach helps ensure every patient receives care based on their unique needs.
Connect with Dr. Abdel-Misih and other mesothelioma specialists by using our Free Doctor Match tool today.
What Health Conditions Does Dr. Sherif Abdel-Misih Treat?
Dr. Abdel-Misih specializes in treating cancers affecting the abdomen and digestive system, with a particular focus on rare and complex tumors.
His primary areas of treatment include:
- Adrenal tumors
- Colon cancer
- Gastrointestinal cancers
- Liver cancer
- Melanoma
- Neuroendocrine tumors
- Pancreatic cancer
- Peritoneal metastases
- Sarcoma
Many of these conditions require coordinated care involving multiple specialists. Dr. Abdel-Misih develops individualized treatment plans designed to address each patient’s diagnosis, overall health, and long-term treatment goals.
Dr. Sherif Abdel-Misih’s Mesothelioma Treatment Approach
Sherif R. Z. Abdel-Misih, MD, provides specialized care for patients diagnosed with peritoneal mesothelioma. Because every patient’s diagnosis is unique, he develops individualized treatment plans based on patient-specific factors and the latest research.
When appropriate, his treatment approach may include:
- Clinical trial participation when appropriate
- Combined surgery and systemic therapy
- Complex abdominal tumor removal
- Cytoreductive surgery with HIPEC
- Multidisciplinary cancer care
Each treatment plan is designed to provide the most effective care while supporting the patient’s quality of life.
If you’re looking for more information on which mesothelioma treatments are right for you, use our Free Doctor Questions Checklist to learn more.
Dr. Sherif Abdel-Misih’s Medical Background
Dr. Abdel-Misih has built his career around treating complex abdominal cancers with surgical removal. His experience in surgical oncology allows him to care for patients with rare cancers, including peritoneal mesothelioma and other peritoneal surface cancers.
He serves as a Clinical Professor of Surgery at Stony Brook Medicine in New York. In addition to treating patients, he teaches future physicians and contributes to ongoing cancer research.
Dr. Abdel-Misih’s Work Experience
Dr. Abdel-Misih has completed extensive training in surgical oncology and has held academic and clinical positions throughout his career.
His experience includes:
- Surgical oncologist at Stony Brook University Hospital
- Fellowship in Complex General Surgical Oncology at Ohio State University Hospital
- Surgical residency at Cleveland Clinic Foundation
- Medical degree from Sidney Kimmel Medical College at Thomas Jefferson University
Highlights of Dr. Sherif Abdel-Misih’s Medical Career
Dr. Abdel-Misih has dedicated his career to expanding treatment options for patients with peritoneal surface cancers.
Throughout his career, he has:
- Contributed to research involving advanced abdominal cancers
- Helped educate future surgeons on surgical techniques like a hepatectomy
- Expanded the use of cytoreductive surgery with HIPEC for certain patients
- Participated in multiple cancer care programs
- Specialized in the treatment of peritoneal mesothelioma and other peritoneal surface cancers
His work reflects a continued commitment to improving treatment options for patients with rare and challenging cancers.
Dr. Abdel-Misih’s Awards and Accolades
Dr. Sherif Abdel-Misih has earned recognition for his clinical expertise, academic leadership, and commitment to patient care.
His awards and accolades include:
- Department of Surgery Faculty Teacher of the Year Award (Ohio State University 2019)
- Top Doctor – Surgery (Castle Connolly 2017-2019)
- Top Doctor – Surgery (Columbus Monthly Magazine 2017-2018)
- Department of Surgery Michael J. Walker, M.D. Faculty Teaching Award (Ohio State University 2014)
- Top Patient Satisfaction (Patient satisfaction survey data 2013-2018)
- Department of Surgery Fellow Teaching Award (Ohio State University 2010)
- Department of Surgery Fellow Teaching Award (Ohio State University 2009)
Dr. Sherif Abdel-Misih’s Work in Cancer Treatment & Clinical Research
In addition to caring for patients, Dr. Abdel-Misih has authored and contributed to peer-reviewed research on peritoneal mesothelioma, cytoreductive surgery with HIPEC, and other cancer treatments.
His clinical research includes:
- Assessing the annual risk of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse malignant peritoneal mesothelioma patients. Published in the Annals of Surgical Oncology, September 2025.
- State-of-the-art therapy in peritoneal carcinomatosis management. Published in Onco, April 2025.
- Gender-based differences in medical student self-ratings of clinical performance. Published in the Journal of Surgical Research, October 2024.
- Comparison of outcomes of abdominoperineal resection vs low anterior resection in very-low rectal cancer. Published in the Journal of Gastrointestinal Surgery, September 2024.
- Close distal margin is associated with locoregional rectal cancer recurrence: A multicenter study. Published in the Journal of Surgical Oncology, July 2023.
- Conditional survival following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: An analysis from the US HIPEC collaborative. Published in the Annals of Surgical Oncology, October 2022.
Use our Free Doctor Match service to connect with Dr. Abdel-Misih or another specialist who can develop the best treatment plan for your mesothelioma diagnosis.
Get Connected With Dr. Sherif Abdel-Misih
Dr. Sherif Abdel-Misih is recognized for his expertise in treating peritoneal mesothelioma with advanced surgical techniques in combination with targeted therapies. If you or a loved one are interested in meeting Dr. Abdel-Misih after being diagnosed with peritoneal mesothelioma, our Patient Advocates are here to help.
Use our Free Doctor Match tool or call (866) 608-8933 to connect with Dr. Sherif Abdel-Misih or other mesothelioma specialists, locate treatment centers, and access support resources.
Mesothelioma Hope has no affiliation with and is not endorsed or sponsored by Dr. Sherif Abdel-Misih. Any contact information listed is for informational purposes only. You have the right to contact Dr. Sherif Abdel-Misih directly.
Content You Can Trust
Jenna Tozzi, RN, is the Chief Patient Care Advisor for Mesothelioma Hope. With more than 15 years of experience as an adult and pediatric oncology nurse navigator, Jenna provides exceptional guidance and support to cancer patients and their loved ones. Jenna has been featured in Oncology Nursing News and is a member of the Academy of Oncology Nurse & Patient Navigators & the American Nurses Association.
